Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajun Du

Showing results (41-50 of 193) with videos related to

Pageof 20
Sort By:
Medical Oncology (Northwood, London, England)|December 17, 2013
High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinomaPing Sui, Pingping Hu, Tiehong Zhang, et al.
Aging|August 25, 2022
Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinomaJichang Liu, Yadong Wang, Xiaogang Zhao, et al.
Medicine|May 15, 2019
Prognostic value of IGF-1R in lung cancer: A PRISMA-compliant meta-analysisJun Xu, Fenglong Bie, Yadong Wang, et al.
European Journal of Clinical Investigation|September 27, 2014
Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysisPing Zhang, Pingping Hu, Hongchang Shen, et al.
The International Journal of Biochemistry & Cell Biology|January 13, 2015
PKD1 is downregulated in non-small cell lung cancer and mediates the feedback inhibition of mTORC1-S6K1 axis in response to phorbol esterYang Ni, Liguang Wang, Jihong Zhang, et al.
Clinical Lung Cancer|August 6, 2013
Response to first-line chemotherapy in patients with non-small-cell lung cancer according to epidermal growth factor receptor and K-RAS mutation statusXiaopeng Dong, Xiaogang Zhao, Yingtao Hao, et al.
Plos One|March 21, 2014
Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expressionXiaopeng Dong, Yingtao Hao, Yucheng Wei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 14, 2025
Multi-omics integrative analysis elucidates the molecular characteristics of SMARCA4-deficient lung adenocarcinoma and the derived therapeutic optionsDeyu Guo, Kai Wang, Shijie Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 8, 2015
Combination of DC Vaccine and Conventional ChemotherapeuticsWei Dong, Ran Wei, Hongchang Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 10, 2014
Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junctionPingping Hu, Zhaofei Pang, Hongchang Shen, et al.
Pageof 20

Showing results (41-50 of 193) with videos related to

Sort By:
Pageof 20
Medical Oncology (Northwood, London, England)|December 17, 2013
High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinomaPing Sui, Pingping Hu, Tiehong Zhang, et al.
Aging|August 25, 2022
Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinomaJichang Liu, Yadong Wang, Xiaogang Zhao, et al.
Medicine|May 15, 2019
Prognostic value of IGF-1R in lung cancer: A PRISMA-compliant meta-analysisJun Xu, Fenglong Bie, Yadong Wang, et al.
European Journal of Clinical Investigation|September 27, 2014
Prognostic role of Twist or Snail in various carcinomas: a systematic review and meta-analysisPing Zhang, Pingping Hu, Hongchang Shen, et al.
The International Journal of Biochemistry & Cell Biology|January 13, 2015
PKD1 is downregulated in non-small cell lung cancer and mediates the feedback inhibition of mTORC1-S6K1 axis in response to phorbol esterYang Ni, Liguang Wang, Jihong Zhang, et al.
Clinical Lung Cancer|August 6, 2013
Response to first-line chemotherapy in patients with non-small-cell lung cancer according to epidermal growth factor receptor and K-RAS mutation statusXiaopeng Dong, Xiaogang Zhao, Yingtao Hao, et al.
Plos One|March 21, 2014
Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expressionXiaopeng Dong, Yingtao Hao, Yucheng Wei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|September 14, 2025
Multi-omics integrative analysis elucidates the molecular characteristics of SMARCA4-deficient lung adenocarcinoma and the derived therapeutic optionsDeyu Guo, Kai Wang, Shijie Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 8, 2015
Combination of DC Vaccine and Conventional ChemotherapeuticsWei Dong, Ran Wei, Hongchang Shen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 10, 2014
Tumor-infiltrating neutrophils predict poor outcome in adenocarcinoma of the esophagogastric junctionPingping Hu, Zhaofei Pang, Hongchang Shen, et al.
Pageof 20